People
Sophia is an associate in the Corporate, Finance and Investments practice group. Sophia is an active member of the firm's Emerging Companies and Venture Capital group, and her practice focuses on equity financings, mergers and acquisitions, capitalization, and corporate governance matters.
Sophia received her J.D. and M.B.A. from University of California, Davis where she served as a Senior Articles Editor of the UC Davis Law Review and President of the King Hall Intellectual Property Law Association. Sophia has previous experience supporting the business and customer operations of various emerging and global innovation companies.
B.A. in History and German Studies, University of Virginia
J.D./M.B.A., UC Davis School of Law, Beta Gamma Sigma
California
Virginia
September 19, 2024
Nuclear Regulatory Commission Issues Construction Permit for King & Spalding Client Natura Resources’ Molten Salt Reactor To Be Deployed at ACU
March 30, 2022
Eleanor Health Holdings Completes $50 million Series C Financing
April 16, 2021
CDC and FDA Release Joint Statement on Johnson & Johnson COVID-19 Vaccine
April 16, 2021
HHS Office for Civil Rights Publishes Legal Guidance Around Access to COVID-19 Vaccines for People with Disabilities and Older Adults
February 22, 2021
FDA Issues Additional Guidance for Medical Product Developers Addressing Virus Variants
September 19, 2024
Nuclear Regulatory Commission Issues Construction Permit for King & Spalding Client Natura Resources’ Molten Salt Reactor To Be Deployed at ACU
March 30, 2022
Eleanor Health Holdings Completes $50 million Series C Financing
April 16, 2021
CDC and FDA Release Joint Statement on Johnson & Johnson COVID-19 Vaccine
April 16, 2021
HHS Office for Civil Rights Publishes Legal Guidance Around Access to COVID-19 Vaccines for People with Disabilities and Older Adults
February 22, 2021
FDA Issues Additional Guidance for Medical Product Developers Addressing Virus Variants
September 19, 2024
Nuclear Regulatory Commission Issues Construction Permit for King & Spalding Client Natura Resources’ Molten Salt Reactor To Be Deployed at ACU
March 30, 2022
Eleanor Health Holdings Completes $50 million Series C Financing
B.A. in History and German Studies, University of Virginia
J.D./M.B.A., UC Davis School of Law, Beta Gamma Sigma
California
Virginia